G. Olinger

发表

CD4-Negative Cells Bind Human Immunodeficiency Virus Type 1 and Efficiently Transfer Virus to T Cells

G. Spear, G. Olinger, M. Saifuddin, 2000, Journal of Virology.

Association of indicators of bacterial vaginosis with a female genital tract factor that induces expression of HIV-1.

B. Sha, G. Spear, F. Hashemi, 1999, AIDS.

Cellular factors influence the binding of HIV type 1 to cells.

M. Hart, G. Spear, G. Olinger, 2002, AIDS research and human retroviruses.

Filoviruses and the balance of innate, adaptive, and inflammatory responses.

Lieping Chen, M. Mohamadzadeh, W. Pratt, 2006, Viral immunology.

Gene-Specific Countermeasures against Ebola Virus Based on Antisense Phosphorodiamidate Morpholino Oligomers

D. A. Stein, P. Iversen, M. Aman, 2006, PLoS pathogens.

Vaccinating captive chimpanzees to save wild chimpanzees

M. Aman, R. Unfer, Kelly L Warfield, 2014, Proceedings of the National Academy of Sciences.

Protective mAbs and Cross-Reactive mAbs Raised by Immunization with Engineered Marburg Virus GPs

D. Kim, K. Whaley, L. Zeitlin, 2015, PLoS pathogens.

Bacterial vaginosis-associated microflora isolated from the female genital tract activates HIV-1 expression.

A. Landay, K. Roebuck, B. Sha, 1999, Journal of acquired immune deficiency syndromes.

Global health security threats and related risks in Latin America

Kenneth B Yeh, J. Fair, B. Borgert, 2021, Global Security: Health, Science and Policy.

FGI-104: a broad-spectrum small molecule inhibitor of viral infection.

M. Kinch, L. Hensley, J. Christopher-Hennings, 2009, American journal of translational research.

Activation of Triggering Receptor Expressed on Myeloid Cells-1 on Human Neutrophils by Marburg and Ebola Viruses

G. Ruthel, W. Kalina, D. Kuhns, 2006, Journal of Virology.

Induction of Humoral and CD8+ T Cell Responses Are Required for Protection against Lethal Ebola Virus Infection1

D. Swenson, S. Bavari, E. Deal, 2005, The Journal of Immunology.

against Lethal Ebola Virus Infection Responses Are Required for Protection T Cell + Induction of Humoral and CD8

D. Swenson, S. Bavari, E. Deal, 2005 .

The cyanobacterial lectin scytovirin displays potent in vitro and in vivo activity against Zaire Ebola virus.

M. Bray, J. Mcmahon, J. Huggins, 2014, Antiviral research.

Ebola virus inactivation with preservation of antigenic and structural integrity by a photoinducible alkylating agent.

W. Kalina, R. Blumenthal, M. Aman, 2007, The Journal of infectious diseases.

Mannose-binding lectin binds to Ebola and Marburg envelope glycoproteins, resulting in blocking of virus interaction with DC-SIGN and complement-mediated virus neutralization.

H. Gewurz, G. Spear, G. Olinger, 2005, The Journal of general virology.

Filovirus-like particles produced in insect cells: immunogenicity and protection in rodents.

J. Hartley, R. Hopkins, D. Esposito, 2007, The Journal of infectious diseases.

Standardization of the Filovirus Plaque Assay for Use in Preclinical Studies

A. Kuehne, A. Griffiths, S. Bavari, 2012, Viruses.

High-Dose Mannose-Binding Lectin Therapy for Ebola Virus Infection

E. Schmidt, G. Spear, I. Michelow, 2011, The Journal of infectious diseases.

Donor variability in HIV binding to peripheral blood mononuclear cells

G. Spear, G. Olinger, J. Anzinger, 2008, Virology Journal.

A Novel L-ficolin/Mannose-binding Lectin Chimeric Molecule with Enhanced Activity against Ebola Virus*

E. Schmidt, G. Houen, T. B. Kinane, 2010, The Journal of Biological Chemistry.

Fighting Ebola with novel spore decontamination technologies for the military

Peter Setlow, Alexander J. Malkin, Christopher J. Doona, 2015, Front. Microbiol..

Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge.

W. Kalina, M. Aman, D. Swenson, 2007, The Journal of infectious diseases.

Discovery of common marburgvirus protective epitopes in a BALB/c mouse model

W. Kalina, S. Bavari, Kelly L. Warfield, 2009, Virology Journal.

Development of a model for marburgvirus based on severe-combined immunodeficiency mice

Steven B. Bradfute, W. Kalina, S. Bavari, 2007, Virology Journal.

Protective mAbs and Cross-Reactive mAbs Raised by Immunization with Engineered Marburg Virus GPs

K. Whaley, L. Zeitlin, E. Saphire, 2015, PLoS pathogens.

Therapeutics Against Filovirus Infection.

G. Kobinger, J. Connor, G. Olinger, 2017, Current topics in microbiology and immunology.

The role of the complement system in virus infections.

G. Spear, F. Hashemi, G. Olinger, 2001, Current topics in microbiology and immunology.

Human Antibodies to Major Histocompatibility Complex Alloantigens Mediate Lysis and Neutralization of HIV‐1 Primary Isolate Virions in the Presence of Complement

H. Gebel, G. Spear, G. Olinger, 2001, Journal of acquired immune deficiency syndromes.

Lectin-Dependent Enhancement of Ebola Virus Infection via Soluble and Transmembrane C-type Lectin Receptors

E. Schmidt, Li Chen, Amel Omari, 2013, PloS one.

Alteration of complement protein levels after antiretroviral therapy in HIV-infected persons.

M. Lederman, D. Kuritzkes, H. Kessler, 1999, AIDS research and human retroviruses.

Discovery of common marburg virus protective epitopes in a BALB / c mouse model

W. Kalina, S. Bavari, Kelly L. Warfield, 2009 .

Discovery of common marburgvirus protective epitopes in a BALB/c mouse model

S. Bavari, Kelly L. Warfield, G. Olinger, 2009, Virology Journal.

Donor variability in HIV binding to peripheral blood mononuclear cells

G. Spear, G. Olinger, J. Anzinger, 2008, Virology Journal.

Discovery of common marburgvirus protective epitopes in a BALB/c mouse model

S. Bavari, Kelly L. Warfield, G. Olinger, 2009, Virology Journal.